Cr(III), Zn(II), Ni(II) and Cu(II) complexes of a symmetric Schiff base ligand (L), (Z)-N'-((1E,2E)-1-(2-(p-tolyl)hydrazineylidene)propan-2-ylidene)-2-((E)-1-(2-(p-tolyl)hydrazineylidene)propan-2-ylidene)hydrazine-1-carbohydrazide has been synthesized. Elemental analysis, UV-Visible, FT-IR, mass spectra and conductometric techniques were used to characterise the ligand and its metal complexes. The microorganisms utilized in this study involve Streptococcus mutans, Staphylococcus Aureus (as Gram-positive bacteria), Escherichia Col and Klebsiella pneumonia (as Gram-negative bacteria) and Aspergillus Nigar and Candida albicans (as fungi). Comparing all of the studied species, Cu(II) complex exhibits the highest activity versus tested fungi.
No takes yet. Share an insight, caveat, or question.
El-Sherif et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: